Convalescent Plasma for the Treatment of Patients With Severe COVID-19 Infection
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Evangelos Terpos, MD
National and Kapodistrian University of Athens
Study Chair - Meletios Athanasios Dimopoulos
National and Kapodistrian University of Athens
Principal InvestigatorKOL profile →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- "agios Savas" Oncology Hospital
Athens, Attica, Greece
- "alexandra" General Hospital
Athens, Attica, Greece
- "evangelismos" General Hospital
Athens, Attica, Greece
- "sotiria" General Hospital
Athens, Attica, Greece
- Attikon" University General Hospital
Athens, Chaidari, Greece
- University General Hospital of Patras
Pátrai, Rio, Greece
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 23 Apr 2020
- Primary completion
- 30 Aug 2023
- Completion
- 15 Dec 2023
- Last update posted
- 18 Nov 2024
- Registered enrollment
- 60
- Registry id
- NCT04408209
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.